• Language
    • English
    • Español
    • Français
    • русский
    • 中文
    • العربية
    • português
  • News & Media
  • Contact Us
  • FAQ
Sofosvel
  • Home
  • Discover Sofosvel
    • Prescribing Info
  • The Manufacturer
    • Beacon at a Glance
    • Facilities
    • Quality Policy
    • CSR
  • Hepatitis Treatment
    • Other Hepatitis Drugs
  • Order Now
Select Page

The Economic times final

Jul 27, 2016

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • US’ Gilead faces competition from Bangladesh’s Beacon pharma
  • EC Grants Gilead’s Sofosbuvir/Velpatasvir for Chronic Hepatitis C
  • European Commission approves Epclusa for all HCV genotypes
  • FDA approves Epclusa for treatment of chronic Hepatitis C virus infection

HEAD OFFICE

9/B/2,Toyenbee Circular Road,
Motijheel,Dhaka-1223, Bangladesh
Phone: +880-2-57165371/79
Fax: +880-2-57165379
Email: info@beaconpharma.com.bd
Web: www.beaconpharma.com.bd

SR. VICE PRESIDENT

Skype ID: shahariar_tamal
WhatsApp: +8801922121404
WeChat: +8801922121404
IMO: +8801922121404
Viber: +8801922121404
Email: tamal@beaconmedicare.com.bd
Email: beaconbdd@gmail.com

MANAGER

Skype ID: masfikur.rahman
WhatsApp: +8801730026182
IMO: +8801730026182
Viber: +8801730026182
Email: masfik@beaconmedicare.com.bd

Copyright © 2021 sofosvel.com | All Rights Reserved | Developed by Beacon Medicare Limited